Table 2.
Clinical Variables With Aortic Arterial Stiffness In The Coronary Artery Disease Patients With Or Without Metabolic Syndrome
| Variables | No metabolic Syndrome (n = 45) | Metabolic Syndrome (n = 70) | P value | ||
|---|---|---|---|---|---|
| No AS Group (n = 34) | AS Group (n = 11) | No AS Group (n = 40) | AS Group (n = 30) | ||
| Age (years) | 64.82 ± 8.63 | 71.45 ± 5.96 | 62.15 ± 8.45 | 68.97 ± 9.03 | 0.001* |
| Height (cm) | 161.85 ± 6.23 | 161.09 ± 5.91 | 161.25 ± 8.35 | 160.47 ± 10.26 | 0.927 |
| Body weight (kg) | 65.03 ± 10.11 | 65.09 ± 6.25 | 69.43 ± 12.55 | 71.72 ± 13.37 | 0.098 |
| Waist circumference (cm) | 88.50 ± 8.52 | 87.001 ± 8.33 | 94.05 ± 9.47 | 99.20 ± 8.23 | < 0.001* |
| Body mass index (kg/m2) | 24.77 ± 3.15 | 25.15 ± 2.81 | 26.54 ± 3.33 | 27.72 ± 3.55 | 0.004* |
| cfPWV (m/s) | 7.70 ± 1.30 | 11.83 ± 1.02 | 8.46 ± 1.75 | 12.15 ± 2.37 | < 0.001* |
| Systolic blood pressure (mmHg) | 123.15 ± 12.02 | 130.73 ± 17.96 | 131.60 ± 17.13 | 132.04 ± 18.14 | < 0.001* |
| Diastolic blood pressure (mmHg) | 70.15 ± 9.47 | 72.45 ± 7.12 | 73.10 ± 10.93 | 74.57 ± 11.14 | 0.376 |
| Total cholesterol (mg/dL) | 170.26 ± 32.81 | 161.45 ± 38.87 | 164.83 ± 38.51 | 163.13 ± 33.00 | 0.825 |
| Triglycerides (mg/dL) | 103.50 (84.00–130.25) | 95.00 (67.00–127.00) | 157.50 (101.75–233.00) | 138.50(91.75–163.00) | 0.002* |
| HDL-C (mg/dL) | 51.79 ± 12.27 | 46.27 ± 15.16 | 41.83 ± 9.27 | 40.77 ± 10.41 | < 0.001* |
| LDL-C (mg/dL) | 98.18 ± 25.61 | 94.36 ± 31.92 | 94.30 ± 25.23 | 95.73 ± 28.32 | 0.935 |
| Fasting glucose (mg/dL) | 101.00 (95.00–117.25) | 93.00 (89.00–125.00) | 118.50 (101.25–133.75) | 132.50 (107.25–184.00) | 0.001* |
| Blood urea nitrogen (mg/dL) | 15.00 (12.00–17.00) | 13.00 (12.00–19.00) | 16.00 (13.00–19.75) | 19.00 (14.00–23.25) | 0.022* |
| Creatinine (mg/dL) | 1.00 (0.90–1.20) | 1.00 (0.80–1.20) | 1.05 (0.90–1.30) | 1.25 (0.98–1.55) | 0.058 |
| Glomerular filtration rate (mL/min) | 75.06 ± 13.67 | 72.16 ± 14.72 | 69.99 ± 19.829 | 58.62 ± 22.56 | 0.005* |
| Total calcium (mg/dL) | 9.00 ± 0.33 | 9.01 ± 0.33 | 9.26 ± 0.35 | 9.13 ± 0.35 | 0.012* |
| Phosphorus (mg/dL) | 3.43 ± 0.53 | 3.16 ± 0.39 | 3.62 ± 0.58 | 3.63 ± 0.49 | 0.034* |
| Ca X IP product(mg2/dL2) | 30.92 ± 5.03 | 28.49 ± 4.31 | 33.50 ± 5.75 | 33.13 ± 4.43 | 0.011* |
| iPTH (pg/mL) | 54.47 ± 25.86 | 55.50 ± 21.96 | 51.26 ± 32.37 | 52.22 ± 21.91 | 0.944 |
| Insulin (uIU/mL) | 9.33 (4.80–16.14) | 11.11 (6.55–17.79) | 14.63 (9.57–26.33) | 14.50 (9.18–25.59) | 0.026* |
| HOMA-IR | 2.23 (1.31–4.80) | 2.86 (1.36–5.84) | 4.29 (2.92–8.19) | 4.75 (2.91–8.55) | 0.003* |
Notes: Values for continuous variables given as means ± standard deviation and are test by one-way analysis of variance; variables not normally distributed given as medians and interquartile range and are test by Kruskal-Wallis analysis. *P < 0.05 was considered statistically significant.
Abbreviations: AS, arterial stiffness; cfPWV, carotid-femoral pulse wave velocity; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Ca X IP product, calcium-phosphorous product; iPTH, intact parathyroid hormone; HOMA-IR, homeostasis model assessment of insulin resistance.